(Q34361343)

1 August 2017

title

The PRIPS study: screening battery for subjects at risk for Parkinson's disease (English)

1 reference

1 August 2017

1 reference

P Mahlknecht

9

0 references

Jochen Klenk

object named as

J Klenk

12

0 references

Klaus Fassbender

object named as

K Fassbender

13

0 references

Werner Poewe

15

object named as

W Poewe

1 reference

ORCID Public Data File 2021

1 August 2017

1 reference

author name string

D Berg

1

1 reference

1 August 2017

J Godau

2

1 reference

1 August 2017

K Seppi

3

1 reference

1 August 2017

S Behnke

4

1 reference

1 August 2017

I Liepelt-Scarfone

5

1 reference

1 August 2017

S Lerche

6

1 reference

1 August 2017

H Stockner

7

1 reference

1 August 2017

A Gaenslen

8

1 reference

1 August 2017

H Huber

10

1 reference

1 August 2017

K Srulijes

11

1 reference

1 August 2017

W Maetzler

14

1 reference

1 August 2017

PRIPS study group

16

1 reference

1 August 2017

publication date

1 August 2012

1 reference

European Journal of Neurology

1 August 2017

published in

1 reference

1 August 2017

volume

20

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

102-108

1 reference

The need for neuroprotective therapies in Parkinson's disease: a clinical perspective

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Subjective complaints precede Parkinson disease: the rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Clinical prediction of Parkinson's disease: planning for the age of neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Transcranial sonography in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Olfactory impairment in presymptomatic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Prevalence of olfactory dysfunction: the Skövde population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

The role of radiotracer imaging in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

A deformation-based morphometry study of patients with early-stage Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Parkinson's at risk syndrome: can Parkinson's disease be predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Biomarkers for the early detection of Parkinson's and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

Reproducibility of sonographic measurement of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03798.X

10.1111/J.1468-1331.2012.03798.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference